HCRTR1 and insomnia: The unique aspect of lemborexant as a DORA is that it could potentially ameliorate problems in sleep architecture and help to normalize the sleep cycle and sleep architecture in patients with insomnia through its binding to both OX1R and OX2R [5,13].